# Relapse Prevention With Varenicline

> **NCT00944554** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 104 (actual)

## Conditions studied

- Recurrence
- Smoking Cessation
- Substance-Related Disorders

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00944554
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2017-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944554, "Relapse Prevention With Varenicline". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00944554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*